Skip to main content
. 2022 Oct 7;13:906420. doi: 10.3389/fimmu.2022.906420

Figure 1.

Figure 1

Gene expression and prognostic value of DERL3 in LUAD patients. (A, B) Pan-cancer analysis of DERL3 expression across RNA-seq datasets from TCGA. (C) Expression of DERL3 in normal pulmonary and stage I LUAD tissues. (D) Kaplan–Meier analysis of DERL3 expression with overall survival (OS) and first progression (FP) values in LUAD patients. (E, F) Immunohistochemistry of DERL3 expression in normal pulmonary and LUAD tissues based on HPA database. (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, ns, not significant).